Symbol: |
CYP2A13
|
Description: |
cytochrome P450, family 2, subfamily A, polypeptide 13 [Source:HGNC Symbol;Acc:2608]
|
Location: |
Chr19:41594368-41602099[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:154
Gene |
Compound |
Gen_sig |
Exp_pattern |
CYP2A13 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.018 |
Up |
CYP2A13 |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.019 |
Up |
CYP2A13 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.027 |
Up |
CYP2A13 |
9-AMINO-20-CAMPTOTHECIN |
0.047 |
Up |
CYP2A13 |
Naphtho[2,3-d]thiazole-4,9-dione, 2-[(4-nitrophenyl) amino]- |
0.028 |
Up |
CYP2A13 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.033 |
Up |
CYP2A13 |
NSC 633912 |
0.047 |
Up |
CYP2A13 |
NSC 634398 |
0.045 |
Up |
CYP2A13 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.017 |
Up |
CYP2A13 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride |
0.043 |
Up |
CYP2A13 |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.032 |
Up |
CYP2A13 |
NSC 648624 |
0.044 |
Down |
CYP2A13 |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.013 |
Up |
CYP2A13 |
NSC 651593 |
0.02 |
Up |
CYP2A13 |
NSC 651668 |
0.02 |
Up |
Expression pattern: Sensitivity / Resistance
Total:11 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:7
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:22
Total:2 Current:1
[First] [Prev]  Next Last 
|